Literature DB >> 18007609

Genetic knockouts and knockins in human somatic cells.

Carlo Rago1, Bert Vogelstein, Fred Bunz.   

Abstract

Gene targeting by homologous recombination with exogenous DNA constructs is the most powerful technique available for analysis of mammalian gene function. Over the past several years, the methods used to generate knockout and knockin mice have been modified for use in cultured human cells. The most significant innovation has been the adaptation of recombinant adeno-associated viruses (rAAVs) for such targeting. The stages of rAAV-mediated gene targeting include (i) the design and construction of a DNA targeting vector, (ii) the production of an infectious rAAV stock, (iii) the generation of cell clones that harbor rAAV transgenes, (iv) screening for homologous recombinants and (v) the iterative targeting of multiple alleles. The protocol described herein allows the generation of a cell line with a single altered allele in 3 months. A second allele of the same gene can be targeted in an additional 3 months.

Entities:  

Mesh:

Year:  2007        PMID: 18007609     DOI: 10.1038/nprot.2007.408

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  77 in total

1.  The E3 ubiquitin ligase MIB1 negatively regulates basal IκBα level and modulates NF-κB activation.

Authors:  Li-Juan Liu; Tian-Tian Liu; Yong Ran; Ying Li; Xiao-Dong Zhang; Hong-Bing Shu; Yan-Yi Wang
Journal:  Cell Res       Date:  2011-12-20       Impact factor: 25.617

2.  Chaperone-mediated autophagy prevents apoptosis by degrading BBC3/PUMA.

Authors:  Wei Xie; Lei Zhang; Haifeng Jiao; Li Guan; Junmin Zha; Xiaotong Li; Mian Wu; Zhanxiang Wang; Jiahuai Han; Han You
Journal:  Autophagy       Date:  2015       Impact factor: 16.016

3.  Mitochondrial respiration protects against oxygen-associated DNA damage.

Authors:  Ho Joong Sung; Wenzhe Ma; Ping-yuan Wang; James Hynes; Tomas C O'Riordan; Christian A Combs; J Philip McCoy; Fred Bunz; Ju-gyeong Kang; Paul M Hwang
Journal:  Nat Commun       Date:  2010-04-12       Impact factor: 14.919

Review 4.  Viral manipulation of DNA repair and cell cycle checkpoints.

Authors:  Mira S Chaurushiya; Matthew D Weitzman
Journal:  DNA Repair (Amst)       Date:  2009-05-26

5.  Hypersensitivities for acetaldehyde and other agents among cancer cells null for clinically relevant Fanconi anemia genes.

Authors:  Soma Ghosh; Surojit Sur; Sashidhar R Yerram; Carlo Rago; Anil K Bhunia; M Zulfiquer Hossain; Bogdan C Paun; Yunzhao R Ren; Christine A Iacobuzio-Donahue; Nilofer A Azad; Scott E Kern
Journal:  Am J Pathol       Date:  2013-11-06       Impact factor: 4.307

6.  Deletion of PTEN promotes tumorigenic signaling, resistance to anoikis, and altered response to chemotherapeutic agents in human mammary epithelial cells.

Authors:  Michele I Vitolo; Michele B Weiss; Marta Szmacinski; Khola Tahir; Todd Waldman; Ben Ho Park; Stuart S Martin; David J Weber; Kurtis E Bachman
Journal:  Cancer Res       Date:  2009-10-20       Impact factor: 12.701

7.  Rare codons regulate KRas oncogenesis.

Authors:  Benjamin L Lampson; Nicole L K Pershing; Joseph A Prinz; Joshua R Lacsina; William F Marzluff; Christopher V Nicchitta; David M MacAlpine; Christopher M Counter
Journal:  Curr Biol       Date:  2012-12-13       Impact factor: 10.834

8.  Cdk2 is required for p53-independent G2/M checkpoint control.

Authors:  Jon H Chung; Fred Bunz
Journal:  PLoS Genet       Date:  2010-02-26       Impact factor: 5.917

9.  Search for informative polymorphisms in candidate genes: clock genes and circadian behaviour in blue tits.

Authors:  C Steinmeyer; J C Mueller; B Kempenaers
Journal:  Genetica       Date:  2008-09-16       Impact factor: 1.082

10.  Ku regulates the non-homologous end joining pathway choice of DNA double-strand break repair in human somatic cells.

Authors:  Farjana Fattah; Eu Han Lee; Natalie Weisensel; Yongbao Wang; Natalie Lichter; Eric A Hendrickson
Journal:  PLoS Genet       Date:  2010-02-26       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.